BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34849006)

  • 1. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma.
    Zhang X; Ping S; Wang A; Li C; Zhang R; Song Z; Gao C; Wang F
    Int J Gen Med; 2021; 14():8611-8620. PubMed ID: 34849006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
    Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X
    Front Oncol; 2021; 11():665870. PubMed ID: 34123829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs.
    Chen S; Sun Y; Zhu X; Mo Z
    Int J Gen Med; 2021; 14():8149-8160. PubMed ID: 34803397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immune-Related Gene Pairs Signature for Predicting Survival in Glioblastoma.
    Wang S; Xu X
    Front Oncol; 2021; 11():564960. PubMed ID: 33859933
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and Validation of an Individualized Immune Prognostic Signature for Recurrent Prostate Cancer.
    Jin Y; Wang L; Lou H; Song C; He X; Ding M
    Comb Chem High Throughput Screen; 2021; 24(1):98-108. PubMed ID: 32593277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
    Li N; Yu K; Lin Z; Zeng D
    Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
    Zhang LH; Li LQ; Zhan YH; Zhu ZW; Zhang XP
    Front Mol Biosci; 2021; 8():607090. PubMed ID: 33937319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 9. Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
    Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu HG; Zhong J
    Radiother Oncol; 2022 Oct; 175():93-100. PubMed ID: 35998839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prognostic DNA Damage Repair Genes Signature and Its Impact on Immune Cell Infiltration in Glioma.
    Wang G; Zhou H; Tian L; Yan T; Han X; Chen P; Li H; Wang W; Xiao Z; Hou L; Xue X
    Front Oncol; 2021; 11():682932. PubMed ID: 34123852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A signature of 18 immune-related gene pairs to predict the prognosis of pancreatic cancer patients.
    Bu F; Nie H; Zhu X; Wu T; Lin K; Zhao J; Huang J
    Immun Inflamm Dis; 2020 Dec; 8(4):713-726. PubMed ID: 33128857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 15. A 25 Immune-Related Gene Pair Signature Predicts Overall Survival in Cervical Cancer.
    Chen H; Xie H; Wang P; Yan S; Zhang Y; Wang G
    Cancer Inform; 2022; 21():11769351221090921. PubMed ID: 35464777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
    Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
    PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma.
    Zhang N; Ge M; Jiang T; Peng X; Sun H; Qi X; Zou Z; Li D
    Front Oncol; 2021; 11():592211. PubMed ID: 33928021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of an 11-Ferroptosis Related Gene Signature and Its Correlation With Immune Checkpoint Molecules in Glioma.
    Chen Z; Wu T; Yan Z; Zhang M
    Front Cell Dev Biol; 2021; 9():652599. PubMed ID: 34249910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients.
    Xiang Z; Chen X; Lv Q; Peng X
    Front Genet; 2021; 12():697819. PubMed ID: 34408772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.